Sanara MedTech Profit Margin

Sanara MedTech (SMTI) currently reports a profit margin of -29.16% as of June 2026. That compares with -10.22% in the prior-year period — down 185.3% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Sanara MedTech's profit margin history and peer comparisons.

Sanara MedTech's profit margin decreased from -10.22% to -29.16% — a 185.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sanara MedTech's profit margin of -29.16% is lower than the Healthcare sector average of 13.89%. That is roughly 309.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Sanara MedTech's current -29.16% should be judged against Healthcare norms (sector average: 13.89%) and against SMTI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -29.16%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Sanara MedTech, and consider following SMTI for alerts when major investors trade the stock.